Surgery Partners Inc (NASDAQ: SGRY). Extremely significant negative changes in technical position have recently occurred: stock price penetrates 200 day m.a. from above, and stock price fell on very heavy volume.
Current PriceTarget Research Rating
Surgery Partners has a current Value Trend Rating of C (High Neutral). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Surgery Partners has a neutral Power Rating of 59 and a slightly positive Appreciation Score of 63, producing the High Neutral Value Trend Rating.
Rating Review
Surgery Partners Inc (NASDAQ: SGRY). Extremely significant negative changes in technical position have recently occurred: stock price penetrates 200 day m.a. from above, and stock price fell on very heavy volume.
Be the first to comment